Sponsor pipeline

Anagram Therapeutics, Inc. clinical trial pipeline

Get alerts when Anagram Therapeutics, Inc.'s trials change

1 active trials 1 recruiting 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07450547 Phase 2 Study to Assess the Safety and Efficacy of ANG003 Exocrine Pancreatic Insufficiency (EPI) Recruiting 2026-10-06

Disease areas by active trials

Cystic Fibrosis (1)

Get alerts when Anagram Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free